Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Senolytic Agent to Improve the Benefit of Platelet-Rich Plasma and Losartan for Treatment of Femoroacetabular Impingement and Labral Tear: A Pilot Study

NCT05025956 is registered in ClinicalTrials.gov with Steadman Philippon Research Institute as lead sponsor.

NCT NCT05025956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Senolytic Agent to Improve the Benefit of Platelet-Rich Plasma and Losartan for Treatment of Femoroacetabular Impingement and Labral Tear: A Pilot Study
Lead sponsor
Steadman Philippon Research Institute
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 24, 2021
Completion date
October 31, 2024
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoroacetabular impingement